Whistleblower Says Celgene Bribed Docs To Sell Cancer Meds

Law360, New York (February 6, 2014, 7:59 PM EST) -- A former sales representative for Celgene Corp. is accusing the drugmaker of paying kickbacks to doctors for prescribing its cancer drugs Thalomid and Revlimid, and of marketing them for off-label uses that government programs including Medicare ended up paying for, according to court documents unsealed Thursday.

Relator Beverly Brown, who worked for Celgene for a decade starting in 2001, claimed that although the two drugs were only narrowly approved to treat multiple myeloma — a form of cancer that affects the bone marrow — they were...
To view the full article, register now.